Allogene Therapeutics Ownership | Who Owns Allogene Therapeutics?
Allogene Therapeutics Ownership Summary
Allogene Therapeutics is owned by 74.18% institutional investors, 16.70% insiders, and 9.13% retail investors. Pfizer is the largest institutional shareholder, holding 10.06% of ALLO shares. American Funds SMALLCAP World A is the top mutual fund, with 5.10% of its assets in Allogene Therapeutics shares.
ALLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Allogene Therapeutics | 74.18% | 16.70% | 9.13% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Pfizer | 22.03M | 10.06% | $27.32M |
| Blackrock | 16.45M | 9.72% | $38.32M |
| Tpg gp a | 18.72M | 8.55% | $23.21M |
| Blackrock funding, inc. /de | 17.51M | 8.00% | $21.72M |
| Vanguard group | 9.02M | 4.12% | $11.19M |
| Primecap management co/ca/ | 7.08M | 3.23% | $8.78M |
| Woodline partners lp | 4.36M | 1.99% | $5.41M |
| Frazier life sciences management | 3.87M | 1.77% | $4.80M |
| Geode capital management | 3.83M | 1.75% | $4.75M |
| Price t rowe associates inc /md/ | 3.68M | 1.68% | $4.56M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vida ventures advisors | 1.80M | 7.59% | $2.23M |
| Pfizer | 22.03M | 6.25% | $27.32M |
| Wildcat capital management | 2.92M | 2.50% | $3.62M |
| Tpg gp a | 18.72M | 1.26% | $23.21M |
| Patient square capital lp | 2.98M | 0.99% | $3.70M |
| Dafna capital management | 1.38M | 0.42% | $1.71M |
| Harold davidson & associates | 295.43K | 0.17% | $366.34K |
| Frazier life sciences management | 3.87M | 0.14% | $4.80M |
| Lynx1 capital management lp | 546.12K | 0.14% | $677.19K |
| Moloney securities asset management | 514.00K | 0.08% | $637.36K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 16.45M | 0.00% | 6.79M |
| Two sigma investments, lp | 3.38M | 0.01% | 1.77M |
| Ubs group | 3.57M | 0.00% | 1.53M |
| Primecap management co/ca/ | 7.08M | 0.01% | 1.36M |
| Renaissance | 2.89M | 0.00% | 1.22M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -11.15M |
| Lynx1 capital management lp | 546.12K | 0.14% | -10.51M |
| Darwin global management | - | - | -10.48M |
| Goldman sachs group | 1.20M | 0.00% | -4.30M |
| Boxer capital | - | - | -3.85M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jacobs levy equity management | 878.96K | 0.01% | 878.96K | $2.05M |
| Australiansuper pty | 382.14K | 0.00% | 382.14K | $473.86K |
| Bridgeway capital management | 250.00K | 0.01% | 250.00K | $310.00K |
| Headlands | 139.96K | 0.01% | 139.96K | $173.55K |
| Hrt financial lp | 132.53K | 0.00% | 132.53K | $164.00K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -41.00 |
| Raymond james financial | -45.00 |
| Dunhill financial | -70.00 |
| Pnc financial services group | -85.00 |
| Federation des caisses desjardins du quebec | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 166 | 8.50% | 162,395,329 | -2.90% | 74 | 1.27% | 85 | 26.87% | 37 | -11.90% |
| Jun 30, 2025 | 160 | -6.98% | 183,929,908 | -6.69% | 84 | 1.00% | 66 | -27.47% | 47 | 14.63% |
| Mar 31, 2025 | 170 | -1.73% | 196,870,758 | 4.48% | 91 | 1.13% | 90 | -2.17% | 41 | - |
| Dec 31, 2024 | 165 | 5.10% | 185,488,005 | 12.84% | 88 | 1.44% | 89 | 27.14% | 40 | -11.11% |
| Sep 30, 2024 | 156 | -8.77% | 164,386,704 | -0.47% | 78 | 0.82% | 71 | -24.47% | 45 | 9.76% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 11.15M | 5.10% | -1.12M |
| Fidelity Growth Compy Commingled Pl O | 4.58M | 2.19% | - |
| Vanguard US Total Market Shares ETF | 4.34M | 2.00% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.19M | 1.90% | -92.41K |
| Fidelity Select Health Care | 4.00M | 1.88% | -350.00K |
| SPDR® S&P Biotech ETF | 3.90M | 1.84% | -23.78K |
| Fidelity Series Small Cap Opps | 3.54M | 1.69% | -141.30K |
| Vanguard Capital Opportunity Inv | 3.56M | 1.63% | 600.00K |
| iShares Russell 2000 ETF | 3.58M | 1.61% | - |
| T. Rowe Price Health Sciences | 2.72M | 1.23% | -30.52K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2025 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $958.92 |
| Oct 21, 2025 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell | $46.17K |
| Jun 10, 2025 | MESSEMER DEBORAH M. | - | Sell | $52.38K |
| Apr 21, 2025 | Yoshiyama Annie | SVP, Finance | Sell | $13.54K |
| Mar 14, 2025 | Chang David D | President and CEO | Sell | $91.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 9 |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | - |
ALLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools